Anglo-Norwegian healthcare group Nycomed is evaluating the structure of its Amersham Pharmacia Biotech unit, which is 45 percent owned by Pharmacia, Reuters reported.
According to the report, Nycomed CEO Bill Castell said that the company was considering increasing its stake in APB as well as floating the unit
An announcement on the new structure is expected soon.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
Try GenomeWeb Premium now.
You may already have institutional access!
Check if I qualify.
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.